Citadel Advisors
CVM.WS

Citadel Advisors’s Cel-Sci Corp Series S CVM.WS Stock Holding History

Citadel Advisors’s Portfolio CVM.WS Stock Details CVM.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-79
Closed – – 9301
2015
Q1 		$0 Hold
79
– – ﹤0.01% 9032
2014
Q4 		$0 Buy
+79
New +$13 ﹤0.01% 8879

Other funds holding CVM.WS

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EEG
E.E. Geduld $178M AUM 29.34% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FMA
FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Citadel Advisors's CVM.WS Position: Q2 2015 in Review

Citadel Advisors sold out of Cel-Sci Corp Series S (CVM.WS) in Q2 2015, closing a stake of 79 shares.

Citadel Advisors first reported a position in CVM.WS in Q4 2014 and held it in 2 quarters. The position peaked at $0 in Q1 2015. 8 funds tracked by Wall St. Rank hold CVM.WS as of Q2 2015.

  • Citadel Advisors reported no remaining Cel-Sci Corp Series S position as of Q2 2015 after selling out during the quarter.
  • Citadel Advisors sold 79 Cel-Sci Corp Series S shares in Q2 2015.
  • Citadel Advisors first reported a position in Cel-Sci Corp Series S in Q4 2014 and held it in 2 quarters.
  • Citadel Advisors's Cel-Sci Corp Series S position peaked at $0 in Q1 2015.
  • 8 funds tracked by Wall St. Rank held Cel-Sci Corp Series S as of Q2 2015.

Based on Citadel Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.